An observational study in Fever of Unknown Origin, sponsored by University Hospital, Montpellier. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2021-04-20.
Sponsored by University Hospital, Montpellier · Observational
Objective : To explore the diagnostic contribution of the 18F-FDG-PET/CT in a population of patients with classical fever of unknown origin (FUO), to precise its place in the diagnostic decision tree in a real-life setting and to identify factors associated with a diagnostic 18F-FDG-PET/CT.
Methods: All adult patients (age≥18 years) with a diagnosis of classical FUO who underwent a 18F-FDG-PET/CT in the University Hospital of Montpellier (France) between April 2012 and December 2017 were included. True positive 18F-FDG-PET/CT which evidenced a specific disease causing FUO were considered to be contributive.
601 studies on the registry are indexed under Fever; 101 are open to participants now.
This study's enrollment of 44 is below the median of 200 across 188 observational studies indexed under Fever.
Browse Fever studies →University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.
Counted across the registry records on this site, refreshed daily.
This retrospective study included all adult patients (age≥18 years) with a diagnosis of classical FUO who underwent a 18F-FDG-PET/CT in the University Hospital of Montpellier (France) between April 2012 and December 2017.
Exclusion Criteria:
-refusal to participate-
the diagnostic contribution of the 18F-FDG-PET/CT
the diagnostic contribution of the 18F-FDG-PET/CT in a population of patients with classical FUO.
Time frame: day 1
18F-FDG-PET/CT place in the diagnostic decision tree in a real-life setting
18F-FDG-PET/CT place in the diagnostic decision tree in a real-life setting
Time frame: day 1
factors associated with a diagnostic 18F-FDG-PET/CT.
factors associated with a diagnostic 18F-FDG-PET/CT.
Time frame: day 1
Plan to share: Undecided — nc
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Montpellier